DS
TAK icon

David Shaw’s Takeda Pharmaceutical TAK Stock Holding History

David Shaw’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-113,678
Closed -$2.24M – 4246
2019
Q4 		$2.24M Hold
113,678
– – ﹤0.01% 2369
2019
Q3 		$1.96M Hold
113,678
– – ﹤0.01% 2367
2019
Q2 		$2.01M Hold
113,678
– – ﹤0.01% 2238
2019
Q1 		$2.32M Buy
+113,678
New +$2.29M ﹤0.01% 2054

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

David Shaw's TAK Position: Q2 2026 in Review

David Shaw reduced its Takeda Pharmaceutical (TAK) stake by 21% in Q2 2026, selling an estimated $9.15M and leaving 2,049,467 shares worth $32.9M. The position accounts for 0.02% of the portfolio, ranked #994.

David Shaw first reported a position in TAK in Q1 2019 and has held it in 18 quarters since. The position peaked at $66.9M in Q4 2025. 375 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • David Shaw held 2,049,467 shares of Takeda Pharmaceutical worth $32.9M as of Q2 2026.
  • David Shaw sold 553,076 Takeda Pharmaceutical shares in Q2 2026, an estimated $9.15M.
  • Takeda Pharmaceutical made up 0.02% of David Shaw's portfolio in Q2 2026, its #994 holding.
  • David Shaw first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 18 quarters since.
  • David Shaw's Takeda Pharmaceutical position peaked at $66.9M in Q4 2025.
  • 375 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.